← Back to Clinical Trials
Recruiting NCT06698380

NCT06698380 The Effect of Mirror Therapy on Upper Extremity Motor Function in Stroke Rehabilitation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06698380
Status Recruiting
Phase
Sponsor University of Jazan
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 38 participants
Start Date 2024-11-18
Primary Completion 2025-07-30

Eligibility & Interventions

Sex All sexes
Min Age 45 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Conventional Physical TherapyMirror Therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 38 participants in total. It began in 2024-11-18 with a primary completion date of 2025-07-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study aimed to determine the effect of mirror therapy versus conventional physical therapy treatment in improving upper extremity impairments and motor function among chronic hemiplegic subjects. Research Objectives: 1. To discover the effectiveness of conventional physical therapy treatment on improving upper limb motor function among chronic hemiplegic subjects. 2. To find out the effect of mirror therapy along with conventional physical therapy treatment on improving upper limb motor function among chronic hemiplegic subjects. 3. To find out the effectiveness of mirror therapy combined with conventional physical therapy treatment versus conventional physical therapy treatment alone on improving upper extremity motor function among chronic hemiplegic subjects.

Eligibility Criteria

Inclusion Criteria: * Duration of stroke more than six months * Subjects of chronic stroke with left or right hemiplegia. * Genders of male and female with age ranging between forty-five to sixty-five years. * MMSE scores greater than 23 out of 30. * Scored one or one plus on MAS on all muscles of the affected upper limb. * Have normal visual perception. * Able to follow oral commands. Exclusion Criteria: * Unable to follow visual and oral commands. * Unilateral neglect. * Cognitive impairments (MMSE scores less than 24 out of 30), or language deficits. * Any other neurological disorders and recent surgeries. * Previous exposure to MT.

Contact & Investigator

Central Contact

Mohammed Mansour Al Shehri, PhD

✉ moalshehri@jazanu.edu.sa

📞 0503946253

Frequently Asked Questions

Who can join the NCT06698380 clinical trial?

This trial is open to participants of all sexes, aged 45 Years or older, up to 65 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06698380 currently recruiting?

Yes, NCT06698380 is actively recruiting participants. Contact the research team at moalshehri@jazanu.edu.sa for enrollment information.

Where is the NCT06698380 trial being conducted?

This trial is being conducted at Riyadh, Saudi Arabia.

Who is sponsoring the NCT06698380 clinical trial?

NCT06698380 is sponsored by University of Jazan. The trial plans to enroll 38 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology